EUVIMEDOpdag EUVIMED
Crossref

Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis

Qilan Shan, Jiaxue Zhang, Rui Gong, Yang Zhou iD, Jianmiao Xu iD, Zhiqiang Liu iD, Yuguo Zheng iD

Biotechnology and Bioengineering · 2026-10-29

DOI: 10.1002/bit.70425 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2026-10-29. Written by Qilan Shan and 6 co-authors. Institution: State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, China. 47 references. Funded by: National Key R&D Program of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

L‑homoserine is a valuable C4 amino acid with broad applications in agriculture, pharmaceuticals, and daily chemicals. However, existing high‑yielding strains have mainly been evaluated at laboratory scale, and their scale‑up feasibility has not yet been sufficiently verified, leaving industrial production without a direct engineering basis. In this study, a non‐auxotrophic, scalable L‑homoserine high‑producer was constructed by targeting carbon loss, rewiring the metabolic network, and maintaining cofactor balance. Specifically, the threonine branch was dynamically attenuated to reduce product degradation, while the non‑oxidative glycolysis (NOG) pathway was introduced and coupled with the glyoxylate shunt to conserve carbon and redirect flux toward the aspartate pathway, thereby increasing precursor availability. The main biosynthetic pathway and cofactor regeneration were further strengthened to accelerate L‑homoserine synthesis. Ultimately, strain HS25 achieved a titer of 126.5 g/L L‑homoserine,a yield of 0.58 g/g glucose, and a productivity of 1.77 g/L/hin 50 L fermentation. These metabolic engineering strategies are scalable and may serve as a generalizable framework for the industrial production of other aspartate‑derived amino acids and their derivatives.

Subjects

Author keywords

Escherichia colicarbon conservationfed‐batch fermentationl‐homoserinemetabolic engineering

Authors and institutions

  • State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, China.
  • Zhejiang Key Laboratory of Bioorganic Synthesis, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.

ORCID profiles: Yang Zhou, Jianmiao Xu, Zhiqiang Liu, Yuguo Zheng

Funding

  • National Key R&D Program of China

Cite

APA

Shan, Q., Zhang, J., Gong, R., Zhou, Y., Xu, J., Liu, Z., & Zheng, Y. (2026). Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70425

Vancouver

Shan Q, Zhang J, Gong R, Zhou Y, Xu J, Liu Z, et al. Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70425

BibTeX
@article{Shan2026,
  author = {Shan, Qilan and Zhang, Jiaxue and Gong, Rui and Zhou, Yang and Xu, Jianmiao and Liu, Zhiqiang and Zheng, Yuguo},
  title = {Metabolic Remodelingof the NOG Pathway and Glyoxylate Cycle for High‐Yield L‐Homoserine Biosynthesis},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70425}
}
Start for free →